| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Kevin Hern OK01 | 2 | −$65.0K | Sold Aug 24, 26 | |
| Richard Dean Dr McCormick GA06 | 2 | 1 | +$8.0K | Sold Jul 30, 26 |
| Gilbert Cisneros CA31 | 1 | −$8.0K | Trimmed May 15, 26 | |
| Julie Johnson TX32 | 4 | −$32.0K | Sold Dec 18, 25 | |
| Rob Bresnahan PA08 | 2 | 1 | +$8.0K | Bought May 15, 25 |
| Jefferson Shreve IN06 | 1 | −$32.5K | Sold May 8, 25 | |
| George Whitesides CA27 | 1 | −$75.0K | Sold Mar 24, 25 | |
| Bruce Westerman AR04 | 1 | 1 | +$0 | Sold Mar 20, 25 |
| Emily Randall WA06 | 1 | −$8.0K | Sold Jan 6, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Aug 24, 26 | Kevin Hern OK01 | Joint | Sell | $15,001 - $50,000 | Sep 1, 26 (8d) | |
| Jul 30, 26 | Richard Dean Dr McCormick GA06 | Self | Sell | $1,001 - $15,000 | Aug 14, 26 (15d) | |
| May 15, 26 | Gilbert Cisneros CA31 | Self | Sell (part) | $1,001 - $15,000 | Jun 8, 26 (24d) | |
| Mar 20, 26 | Kevin Hern OK01 | Joint | Sell | $15,001 - $50,000 | Apr 3, 26 (14d) | |
| Dec 18, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Jan 15, 26 (28d) | |
| Nov 13, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Dec 11, 25 (28d) | |
| Nov 5, 25 | Richard Dean Dr McCormick GA06 | Self | Buy | $1,001 - $15,000 | Dec 9, 25 (34d) | |
| Aug 14, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Sep 11, 25 (28d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | May 31, 25 (16d) | |
| May 8, 25 | Jefferson Shreve IN06 | Self | Sell | $15,001 - $50,000 | Jun 22, 25 (45d) | |
| May 7, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Aug 5, 26 (455d) | |
| Apr 8, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | Apr 28, 25 (20d) | |
| Mar 24, 25 | George Whitesides CA27 | Self | Sell | $50,001 - $100,000 | Apr 23, 25 (30d) | |
| Mar 20, 25 | Bruce Westerman AR04 | Self | Sell | $1,001 - $15,000 | Apr 16, 25 (27d) | |
| Mar 4, 25 | Bruce Westerman AR04 | Self | Buy | $1,001 - $15,000 | Apr 16, 25 (43d) | |
| Feb 25, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | Mar 27, 25 (30d) | |
| Jan 6, 25 | Emily Randall WA06 | Spouse | Sell | $1,001 - $15,000 | Feb 11, 25 (36d) | |
| Mar 15, 23 | Richard Dean Dr McCormick GA06 | Self | Buy | $1,001 - $15,000 | Sep 17, 25 (917d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Kiil Harry SkipOfficer | Sale at price 93.65 per share. | 1.5K | $138.88K |
| Sep 14, 2026 | Blomquist Denise LOfficer | Stock Gift at price 0.00 per share. | 600 | — |
| Aug 2, 2026 | Thompson KweliOfficer | Stock Award(Grant) at price 0.00 per share. | 6.9K | — |
| Aug 2, 2026 | Martha Geoffrey SChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 41.5K | — |
| Aug 2, 2026 | Quinn MichelleGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 6.3K | — |
| Aug 2, 2026 | Marinaro MichaelOfficer | Stock Award(Grant) at price 0.00 per share. | 57.1K | — |
| Aug 2, 2026 | Walter Matthew R.Officer | Stock Award(Grant) at price 0.00 per share. | 5.8K | — |
| Aug 2, 2026 | Pieton Thierry Jean LouisChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 11.5K | — |
| Aug 2, 2026 | Blomquist Denise LOfficer | Stock Award(Grant) at price 0.00 per share. | 2.3K | — |
| Aug 2, 2026 | Kiil Harry SkipOfficer | Stock Award(Grant) at price 0.00 per share. | 9.2K | — |
| Jul 7, 2026 | Walter Matthew R.Officer | Sale at price 83.15 per share. | 3.1K | $257.93K |
| Jun 7, 2026 | Kiil Harry SkipOfficer | Sale at price 80.44 - 80.45 per share. | 4.2K | $336.96K |
| May 25, 2026 | Marinaro MichaelOfficer | — | 19K | — |
| May 25, 2026 | Walter Matthew R.Officer | — | 9.1K | — |
| May 25, 2026 | Blomquist Denise LOfficer | — | 1.7K | — |
| May 25, 2026 | Martha Geoffrey SChief Executive Officer | — | 95K | — |
| May 25, 2026 | Kiil Harry SkipOfficer | — | 15.2K | — |
| May 25, 2026 | Wall Brett AOfficer | — | 26.9K | — |
| Apr 26, 2026 | Groetelaars John PDirector | Stock Award(Grant) at price 0.00 per share. | 1.4K | — |
| Apr 26, 2026 | Blomquist Denise LOfficer | Stock Award(Grant) at price 0.00 per share. | 1.5K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.2 | -5.1 | -11.3 | -6.6 | -8.8 | 6.0 | 9.2 | 6.2 | -4.8 | 6.5 | −4.3% | ||
| 2025 | 13.7 | 1.3 | -2.3 | -5.7 | -2.1 | 5.0 | 3.5 | 2.8 | 2.6 | -4.8 | 16.1 | -8.8 | +20.3% |
| 2024 | 6.3 | -4.8 | 4.5 | -7.9 | 1.4 | -3.3 | 2.0 | 10.3 | 1.6 | -0.9 | -3.0 | -7.7 | −3.0% |
| 2023 | 7.7 | -1.1 | -2.6 | 12.8 | -9.0 | 6.5 | -0.4 | -7.1 | -3.9 | -10.0 | 12.3 | 3.9 | +6.0% |
| 2022 | 0.0 | 1.4 | 5.7 | -5.9 | -4.0 | -10.4 | 3.1 | -5.0 | -8.2 | 8.2 | -9.5 | -1.7 | −24.9% |
| 2021 | -5.0 | 5.1 | 1.0 | 10.8 | -3.3 | -1.9 | 5.8 | 1.7 | -6.1 | -4.4 | -11.0 | -3.0 | −11.7% |
| 2020 | 1.8 | -12.8 | -10.4 | 8.3 | 1.0 | -7.0 | 5.2 | 11.4 | -3.3 | -3.2 | 13.1 | 3.0 | +3.3% |
| 2019 | -2.8 | 2.4 | 0.6 | -2.5 | 4.2 | 5.2 | 4.7 | 5.8 | 0.7 | 0.3 | 2.3 | 1.8 | +24.7% |
| 2018 | 6.4 | -7.0 | 0.4 | -0.1 | 7.7 | -0.8 | 5.4 | 6.8 | 2.0 | -8.7 | 8.6 | -6.7 | +12.6% |
| 2017 | 6.7 | 6.4 | -0.4 | 3.1 | 1.4 | 5.3 | -5.4 | -4.0 | -3.5 | 3.5 | 2.0 | -1.7 | +13.4% |
| 2016 | -1.3 | 1.9 | -3.1 | 5.5 | 1.7 | 7.8 | 1.0 | -0.7 | -0.7 | -5.1 | -11.0 | -2.4 | −7.4% |
| 2015 | -1.1 | 8.7 | 0.5 | -4.5 | 2.5 | -2.9 | 5.8 | -7.8 | -7.4 | 10.4 | 1.9 | 2.1 | +6.5% |
| 2014 | -1.4 | 4.8 | 3.8 | -4.4 | 3.8 | 4.5 | -3.2 | 3.4 | -3.0 | 10.0 | 8.4 | -2.3 | +25.8% |
| 2013 | 13.6 | -3.5 | 4.4 | -0.6 | 9.3 | 0.9 | 7.3 | -6.3 | 2.9 | 7.8 | -0.1 | 0.1 | +39.9% |
| 2012 | 0.8 | -1.2 | 2.8 | -2.5 | -3.6 | 5.1 | 1.8 | 3.1 | 6.1 | -3.6 | 1.3 | -2.6 | +7.2% |
| 2011 | 3.3 | 4.2 | -1.4 | 6.1 | -2.5 | -5.3 | -6.4 | -2.7 | -5.2 | 4.5 | 4.9 | 5.0 | +3.1% |
| 2010 | -2.5 | 1.2 | 3.8 | -3.0 | -10.3 | -7.4 | 1.9 | -14.9 | 6.8 | 4.9 | -4.8 | 10.6 | −15.7% |
| 2009 | 6.6 | -11.6 | -0.4 | 8.6 | 7.3 | 1.6 | 1.5 | 8.1 | -3.9 | -3.0 | 18.9 | 3.6 | +40.0% |
| 2008 | -7.5 | 6.2 | -2.0 | 0.6 | 4.1 | 2.1 | 2.1 | 3.4 | -8.2 | -19.5 | -24.3 | 2.9 | −37.5% |
| 2007 | -0.1 | -5.8 | -2.6 | 7.9 | 0.5 | -2.5 | -2.3 | 4.3 | 6.8 | -15.9 | 7.2 | -1.1 | −6.1% |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Buy / hold / sell counts